Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype

被引:172
作者
Park, DS
Woodman, SE
Schubert, W
Cohen, AW
Frank, PG
Chandra, M
Shirani, J
Razani, B
Tang, BY
Jelicks, LA
Factor, SM
Weiss, LM
Tanowitz, HB
Lisanti, MP
机构
[1] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA
[2] Albert Einstein Canc Ctr, Div Hormone Dependent Tumor Biol, Bronx, NY USA
[3] Albert Einstein Coll Med, Dept Med, Div Cardiol, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10467 USA
[5] Montefiore Med Ctr, Bronx, NY 10467 USA
[6] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA
[7] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA
关键词
D O I
10.1016/S0002-9440(10)61168-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The caveolin gene family consists of caveolins 1, 2, and 3. Caveolins 1 and 2 are co-expressed in many cell types, such as endothelial cells, fibroblasts, smooth muscle cells and adipocytes, where they form a heteroligomeric complex. In contrast, the expression of caveolin-3 is muscle-specific. Thus, the expression of caveolin-1 is required for caveolae formation in nonmuscle cells, while the expression of caveolin-3 drives caveolae formation in striated muscle cell types (cardiac and skeletal). To create a truly caveolae-deficient mouse, we interbred Cav-1 null mice and Cav-3 null mice to generate Cav-1/Cav-3 double-knockout (Cav-1/3 dKO) mice. Here, we report that Cav-1/3 dKO mice are viable and fertile, despite the fact that they lack morphologically identifiable caveolae in endothelia, adipocytes, smooth muscle cells, skeletal muscle fibers, and cardiac myocytes. We also show that these mice are deficient in all three caveolin gene products, as caveolin-2 is unstable in the absence of caveolin-1. Interestingly, Cav-1/3 dKO mice develop a severe cardiomyopathy. At 2 months of age, analysis of Cav-1/3 dKO hearts via gated magnetic resonance imaging reveals a dramatic increase in left ventricular wall thickness, as compared with Cav-1-KO, Cav-3 KO, and wild-type mice. Further functional analysis of Cav-1/3 dKO hearts via transthoracic echocardiography demonstrates hypertrophy and dilation of the left ventricle, with a significant decrease in fractional shortening. As predicted, Northern analysis of RNA derived from the left ventricle of Cav-1/3 dKO mice shows a dramatic up-regulation of the atrial natriuretic factor message, a well-established biochemical marker of cardiac hypertrophy. Finally, histological analysis of Cav-1/3 dKO hearts reveals hypertrophy, disorganization, and degeneration of the cardiac myocytes, as well as chronic interstitial fibrosis and inflammation. Thus, dual ablation of both Cav-1 and Cav-3 genes in mice leads to a pleiotropic defect in caveolae formation and severe cardiomyopathy.
引用
收藏
页码:2207 / 2217
页数:11
相关论文
共 55 条
  • [1] Nitric oxide synthases and cardiac muscle - Autocrine and paracrine influences
    Balligand, JL
    Cannon, PJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) : 1846 - 1858
  • [2] NITRIC OXIDE-DEPENDENT PARASYMPATHETIC SIGNALING IS DUE TO ACTIVATION OF CONSTITUTIVE ENDOTHELIAL (TYPE-III) NITRIC-OXIDE SYNTHASE IN CARDIAC MYOCYTES
    BALLIGAND, JL
    KOBZIK, L
    HAN, XQ
    KAYE, DM
    BELHASSEN, L
    OHARA, DS
    KELLY, RA
    SMITH, TW
    MICHEL, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) : 14582 - 14586
  • [3] MYOCARDIAL GI-ALPHA-PROTEIN LEVELS IN PATIENTS WITH HYPERTENSIVE CARDIAC-HYPERTROPHY, ISCHEMIC-HEART-DISEASE AND CARDIOGENIC-SHOCK
    BOHM, M
    KIRCHMAYR, R
    ERDMANN, E
    [J]. CARDIOVASCULAR RESEARCH, 1995, 30 (04) : 611 - 618
  • [4] Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil Strain):: an echocardiographic study
    Chandra, M
    Shirani, J
    Shtutin, V
    Weiss, LM
    Factor, SM
    Petkova, SB
    Rojkind, M
    Dominguez-Rosales, JA
    Jelicks, LA
    Morris, SA
    Wittner, M
    Tanowitz, HB
    [J]. INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2002, 32 (02) : 207 - 215
  • [5] Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling
    Dessy, C
    Kelly, RA
    Balligand, JL
    Feron, O
    [J]. EMBO JOURNAL, 2000, 19 (16) : 4272 - 4280
  • [6] Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice
    Drab, M
    Verkade, P
    Elger, M
    Kasper, M
    Lohn, M
    Lauterbach, B
    Menne, J
    Lindschau, C
    Mende, F
    Luft, FC
    Schedl, A
    Haller, H
    Kurzchalia, TV
    [J]. SCIENCE, 2001, 293 (5539) : 2449 - 2452
  • [7] Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo -: Implications for human breast cancer
    Engelman, JA
    Lee, RJ
    Karnezis, A
    Bearss, DJ
    Webster, M
    Siegel, P
    Muller, WJ
    Windle, JJ
    Pestell, RG
    Lisanti, MP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) : 20448 - 20455
  • [8] Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth
    Engelman, JA
    Wykoff, CC
    Yasuhara, S
    Song, KS
    Okamoto, T
    Lisanti, MP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) : 16374 - 16381
  • [9] p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression - Activation of Ras-MAP kinase and protein kinase A signaling cascades transcriptionally down-regulates caveolin-1 promoter activity
    Engelman, JA
    Zhang, XL
    Razani, B
    Pestell, RG
    Lisanti, MP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) : 32333 - 32341
  • [10] JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA
    FARQUHAR, MG
    PALADE, GE
    [J]. JOURNAL OF CELL BIOLOGY, 1963, 17 (02) : 375 - &